Categories
Senores Pharmaceuticals Limited — Updates, 14-05-2026: Press Release (Revised)
14-05-2026 · 05:06 pm
Senores Pharma delivered strong FY26 results: Total Income up 62%, PAT up 108%. Strategic moves include acquiring Zoraya and Apnar Pharma, plus a US federal market JV (Amerisyn), boosting Regulated Markets pipeline and access.
No comments yet. Be the first to comment!